Insider · CIK 0001211703
R Scott Greer
Files at NKTR (NEKTAR THERAPEUTICS). First filing -, latest -.
R Scott Greer files SEC Form 4 as director at NKTR (NEKTAR THERAPEUTICS). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; R Scott Greer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | NKTR NEKTAR THERAPEUTICS | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 22,239 | 18 d ago |
| Sep 23, 2026 | NKTR NEKTAR THERAPEUTICS | AGrant or award Stock Optionderivative | +4,000 | $0.00 | $0 | 4,000 | 18 d ago |
| Sep 30, 2025 | NKTR NEKTAR THERAPEUTICS | AGrant or award Stock Optionderivative | +8,000 | $0.00 | $0 | 8,000 | Oct 1, 2025 |
Questions about R Scott Greer
Answered from the filings on this page, as of the latest one.
Is R Scott Greer buying or selling?
R Scott Greer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did R Scott Greer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and R Scott Greer has 0.
Where does R Scott Greer file Form 4?
R Scott Greer has filed Form 4 at NKTR (NEKTAR THERAPEUTICS). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.